{"id":46155,"date":"2019-10-03T11:07:05","date_gmt":"2019-10-03T09:07:05","guid":{"rendered":"https:\/\/www.fedaiisf.it\/?p=46155"},"modified":"2019-10-03T11:07:05","modified_gmt":"2019-10-03T09:07:05","slug":"novartis-si-allea-con-microsoft-e-punta-sullintelligenza-artificiale","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-si-allea-con-microsoft-e-punta-sullintelligenza-artificiale\/","title":{"rendered":"Novartis allies with Microsoft and focuses on artificial intelligence"},"content":{"rendered":"

The collaboration will lead to the creation of a laboratory, the Novartis Ai Innovation La<\/h4>\n

Tio 20 Ticino \u2013 1.10.2019<\/a><\/p>\n

BASEL \u2013 The pharmaceutical group Novartis and the American company Microsoft have entered into a collaboration in the field of artificial intelligence.<\/p>\n

\n
\"\"<\/a>
TLB courtesy: 12\/11\/2018 \u2013 Imagoeconomica|<\/figcaption><\/figure>\n

The alliance envisages a multi-year commitment to research and development, a strategic collaboration which \u2013 explains the Basel giant in today's press release \u2013 leads to the creation of a laboratory (Novartis Ai Innovation Lab).<\/p>\n

"Combining our deep understanding of human biology and medicine with Microsoft's unique capabilities in artificial intelligence will enable us to transform the way we discover and develop medicines for patients around the world," said CEO Vas Narasimhan, mentioned in the note.<\/p>\n

Related news:\u00a0Novartis and Microsoft join forces to develop drugs using AI<\/span><\/a><\/p>\n<\/div>\n

 <\/p>","protected":false},"excerpt":{"rendered":"

La collaborazione porter\u00e0 alla nascita di un laboratorio, il Novartis Ai Innovation La Tio 20 Ticino – 1.10.2019 BASILEA – Il gruppo farmaceutico Novartis e la societ\u00e0 americana Microsoft hanno avviato una collaborazione nel settore dell’intelligenza artificiale. L’alleanza prevede un impegno pluriennale nella ricerca e sviluppo, una collaborazione strategica che – spiega il colosso basilese …<\/p>","protected":false},"author":4,"featured_media":46161,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-46155","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/46155","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=46155"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/46155\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/46161"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=46155"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=46155"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=46155"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}